NCT02111590View on ClinicalTrials.gov

Immunoglobulin Dosage and Administration Form in CIDP and MMN

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Chronic Inflammatory Demyelinating PolyneuropathyMultifocal Motor NeuropathyHemolytic Anemia
Interventions
DRUG

Immunoglobulins

SCIG dosage is individualized for each patient according to previous IVIG dosage

Trial Locations (1)

2100

Department of Neurology, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Octapharma Pharmazeutika Produktionsges.m.b.H.

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT02111590 - Immunoglobulin Dosage and Administration Form in CIDP and MMN | Biotech Hunter | Biotech Hunter